Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $48 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.